Oral Session 1-12B ALL: Basic (2)

[OS1-12B-2] Prevalence of MEF2D fusions in B-cell precursor acute lymphoblastic leukemia cell lines

Koshi Akahane¹, Takahiko Yasuda², Shinobu Tsuzuki³, Fumihiko Hayakawa⁴, Nobutaka Kiyokawa⁵, Keiko Kagami¹, Masako Abe¹, Daisuke Harama¹, Atsushi Watanabe¹, Kumiko Goi¹, Toshihiko Imamura⁶, Hiroaki Goto⁷, Shotaro Iwamoto⁸, Masayoshi Minegishi⁹, Hiroshi Hojo¹⁰, Toshiya Inaba¹¹, Kanji Sugita¹, Takeshi Inukai¹ (1.Department of Pediatrics, University of Yamanashi, Chuo, Japan, 2.National Hospital Organization Nagoya Medical Center, Nagoya, Japan, 3.Department of Biochemistry, Aichi Medical University, Nagakute, Japan, 4.Department of Pathophysiological Laboratory Sciences, Nagoya University, Nagoya, Japan, 5.National Research Institute for Child Health and Development, Tokyo, Japan, 6.Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan, 7.Kanagawa Childrens Medical Center, Yokohama, Japan, 8.Department of Pediatrics, Mie University, Tsu, Japan, 9.Japanese Red Cross Miyagi Blood Center, Sendai, Japan, 10.Department of Diagnostic Pathology, Fukushima Medical University, Aizuwakamatsu, Japan, 11.Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan)